March 25, 2026
Review
New
Evaluation Report on Applicability to Drug-agnostic Companion Diagnostics,posted
March 25, 2026
Review
New
The information of New Drug Review with Electronic Data updated
March 23, 2026
Other
New
Recent Publications by PMDA Staff updated
March 17, 2026
Safety
Revisions of PRECAUTIONS: Triazolam, etc. posted
March 16, 2026
Review
Points to Consider in the Clinical Development of Radiopharmaceuticals for Positron Emission Tomography Targeting Prostate Specific Membrane Antigen (PSMA PET) (Early Consideration) posted
March 13, 2026
Events
Report of APEC CoE Workshop: PMDA-ATC MRCT/GCP Inspection Seminar 2026
March 25, 2026
Drug
IVD
New
Evaluation Report on Applicability to Drug-agnostic Companion Diagnostics,posted
March 25, 2026
Drug
New
The information of New Drug Review with Electronic Data updated
March 16, 2026
Points to Consider in the Clinical Development of Radiopharmaceuticals for Positron Emission Tomography Targeting Prostate Specific Membrane Antigen (PSMA PET) (Early Consideration) posted
Currently, there is no applicable information.
Currently, there is no applicable information.
Please note that this site may not be accurate due to machine translation, and all files (PDF, Excel, Word, PowerPoint) are not translated.